Presidents

Nicola Mozzillo
Honorary President

Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy

Igor Puzanov
Director Early Phase Clinical Trials Program, Co-Leader Experimental Therapeutics Program, Chief Melanoma Section Department of Medicine Roswell Park Cancer Institute, Buffalo, NY

Ena Wang
Acting CRO
Research Chief, Translational Medicine Division, Research Branch, Sidra Medical and Research Center, Doha, Qatar
Scientific Board

Sanjiv Agarwala
Chief of Medical oncology and Hematology, St. Luke’s University Hospital and Temple University, Bethlehem, Pennsylvania

Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy

Carlo Bifulco
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon

Sandra Demaria
Weill Cornell medical College, New York, NY

Reinhard Dummer
University of Zurich Hospital, Department of Dermatology, Zurich, Switzerland

Bernard A. Fox
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon

Jerome Galon
INSERM (National Institute of Health and Medical Research), Paris, France

Claus Garbe
University Professor of Dermatology, Head, Division of Dermatologic Oncology Department of Dermatology Eberhard Karls University Tuebingen (Stuttgart), Germany

Giuseppe Masucci
Professor, Department of Oncology-Pathology, and KcRN, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden

Michael Postow
Memorial Sloan Kettering Cancer Center, New York

Igor Puzanov
Director Early Phase Clinical Trials Program, Co-Leader Experimental Therapeutics Program, Chief Melanoma Section Department of Medicine Roswell Park Cancer Institute, Buffalo, NY

Magdalena Thurin
Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland

Ena Wang
Acting CRO
Research Chief, Translational Medicine Division, Research Branch, Sidra Medical and Research Center, Doha, Qatar
For information please contact info@melanomabridge.org